‹ ›
MYP_084859
← PREVIOUS NEXT → BACK
Basic Information
HPV-16 L2 Ct
Antimicrobial
Antiviral
Antiviral ▸ Anti-HPV
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition ▸ Entry inhibitor
Enzyme modulation ▸ Enzyme inhibition ▸ Infection inhibition
Standard
9 amino acids
C53H105N23O10S
Standard
Sequence
MLRKRRKRL
Physicochemical Analysis
1256.61 Da
12.00
5.50
5.28
0.6109
-1.81
0.36
-1.15
166.38
86.67
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
595.76
-4.57
24.0
17.0
48.0
87.0
0.0
8.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0205195 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
inhibition of pseudovirions infection
96±20 %
Inhibition
PaperPubMed PMID: 15170645 PMID15170645 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/15170645/
RECORD: Rec_0308490 VERIFIED: YES
Provenance & Taxonomy
Human papillomavirus [Virus]
Virus-derived peptide
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor
Human papillomavirus (Virus entry); Cos-7
96 %
Luciferase assay
PaperPositively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity. | Bousarghin L, Touze A, Yvonnet B, Coursaget P. | J Med Virol. 2004 | PMID:15170645 PMID15170645 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/15170645/
FIRST PREV 1 2
Showing 2 records on this page · Page 2 of 2